Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ivosidenib (AG-120) in patients with IDH1-mutant relapsed/refractory myelodysplastic syndrome: Updated enrollment of a phase 1 dose escalation and expansion study
    Meeting Abstract

    Foran, J. M.; DiNardo, C. D.; Watts, J. M.; Stein, E. M.; De Botton, S.; Fathi, A. T.; Prince, G. T.; Stein, A.; Stone, R. M.; Patel, P. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Aberrant responsiveness of erythropoiesis to iron deficiency in polycythemia vera
    Meeting Abstract

    Feola, M.; Moskop, D.; Terra, N.; Park, Y. C.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Ginzburg, Y.
    Blood (2019)

    Fulltext@MSK | Save
  • Landscape of TP53 mutations in MPN
    Meeting Abstract

    Farnoud, N.; Famulare, C.; Papaemmanuil, E.; McGovern, E.; Medina, J.; Arango Ossa, J. E.; Rampal, R. K.; Li, B.; Levine, R. L.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comparative somatic mutational profiling of CD34+ hematopoietic precursors (HSC) and circulating endothelial cells (CEC) in patients with primary myelofibrosis (PMF)
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; Malagola, M.; Re, F.; Cattina, F.; D'Adda, M.; Rossi, G.; Zollner, T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Dual driver mutant BCR-ABL1-negative myeloid neoplasms: Multicenter clinicopathologic and genomic analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Tripodi, J.; Arcila, M. E.; Sen, F.; Najfeld, V.; Mascarenhas, J.; Hoffman, R.; Rampal, R. K.
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Identifying cytokine biomarkers of response to pegylated-interferon therapy in polycythemia vera and essential thrombocythemia: Correlative analysis from the MPN-RC 111/112 trials
    Meeting Abstract

    Dunbar, A.; Kosiorek, H. E.; Krishnan, A.; McGovern, E.; Park, Y.; Patel, M. A.; Singer Weinberg, R.; Yacoub, A.; Dueck, A. C.; Mascarenhas, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Improved overall survival with enasidenib compared with standard of care among patients with relapsed or refractory acute myeloid leukemia and IDH2 mutations: A propensity score matching analysis using data from the AG221-C-001 trial and two data sources from France and Germany
    Meeting Abstract

    De Botton, S.; Brandwein, J. M.; Stein, E. M.; Wei, A. H.; Weber, D.; Pigneux, A.; Boissel, N.; Paschka, P.; DoĢˆhner, K.; Nehme, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High rate of IDH1 mutation clearance and measurable residual disease negativity in patients with IDH1-mutant newly diagnosed acute myeloid leukemia treated with ivosidenib (AG-120) and azacitidine
    Meeting Abstract

    Daigle, S. R.; Choe, S.; Quek, L.; DiNardo, C. D.; Stein, A.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Kantarjian, H. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia
    Meeting Abstract

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Blood (2019)

    Fulltext@MSK | Save